Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Blood. 2015 Mar 19;125(12):1877-82; quiz 2009. doi: 10.1182/blood-2014-08-551879. Epub 2014 Dec 22.
The identification of pulmonary embolism (PE) on computed tomography scans performed for indications other than identification of thromboembolism is a growing clinical problem that has not been adequately addressed by prospective treatment trials. The prevalence of incidentally detected PE ranges from 1% to 4% in unselected populations, with higher rates among hospital inpatients and patients with cancer. Current guidelines recommend using the same approach to type and duration of anticoagulation as is used for patients with suspected PE. Available data regarding the significance of symptomatic subsegmental PE (SSPE) are conflicting, making it difficult to draw conclusions about the appropriate treatment of incidentally detected SSPE, for which the data are sparse. Among cancer patients, the bulk of available data suggest that incidental SSPE is associated with recurrent venous thromboembolism and, when symptomatic, may adversely impact survival. Here, the topic is reviewed utilizing 3 clinical cases, each of which is followed by a discussion of salient features and then by treatment recommendations.
在非为诊断血栓栓塞而进行的计算机断层扫描(CT)中发现的肺栓塞(PE)的识别是一个日益严重的临床问题,前瞻性治疗试验尚未充分解决这一问题。在未选择的人群中,偶然发现的 PE 的患病率为 1%至 4%,住院患者和癌症患者中的患病率更高。目前的指南建议使用与疑似 PE 患者相同的方法来确定抗凝的类型和持续时间。关于有症状的亚段性 PE(SSPE)的意义的现有数据相互矛盾,这使得难以对偶然发现的 SSPE 的适当治疗做出结论,因为数据很少。在癌症患者中,大多数可用数据表明偶然的 SSPE 与复发性静脉血栓栓塞相关,并且在有症状时可能会对生存产生不利影响。在这里,利用 3 个临床病例对该主题进行了回顾,每个病例后面都讨论了其显著特征,然后提出了治疗建议。